Securities Purchase AgreementSecurity Agreement • November 12th, 2021 • Growlife, Inc. • Glass products, made of purchased glass • Utah
Contract Type FiledNovember 12th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of November 5, 2021, is entered into by and between Growlife, Inc., a Delaware corporation (“Company”), and Bucktown Capital, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”).
Securities Purchase AgreementSecurity Agreement • August 31st, 2021 • Growlife, Inc. • Glass products, made of purchased glass • Utah
Contract Type FiledAugust 31st, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of August 25, 2021, is entered into by and between Growlife, Inc., a Delaware corporation (“Company”), and Bucktown Capital, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”).
Securities Purchase AgreementSecurity Agreement • March 5th, 2021 • Growlife, Inc. • Glass products, made of purchased glass • Utah
Contract Type FiledMarch 5th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of February 26, 2021, is entered into by and between Growlife, Inc., a Delaware corporation (“Company”), and Bucktown Capital, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”).
Securities Purchase AgreementSecurity Agreement • July 30th, 2019 • Growlife, Inc. • Glass products, made of purchased glass • Utah
Contract Type FiledJuly 30th, 2019 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of July 22, 2019, is entered into by and between Growlife, Inc., a Delaware corporation (“Company”), and Odyssey Research and Trading, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”).
Securities Purchase AgreementSecurity Agreement • October 17th, 2018 • Growlife, Inc. • Glass products, made of purchased glass • Utah
Contract Type FiledOctober 17th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of October 15, 2018, is entered into by and between Growlife, Inc., a Delaware corporation (“Company”), and Iliad Research and Trading, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
Securities Purchase AgreementSecurity Agreement • March 28th, 2018 • Growlife, Inc. • Glass products, made of purchased glass • Utah
Contract Type FiledMarch 28th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of December 22, 2017, is entered into by and between Growlife, Inc., a Delaware corporation (“Company”), and Chicago Venture Partners, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
Securities Purchase AgreementSecurity Agreement • August 17th, 2017 • Growlife, Inc. • Glass products, made of purchased glass • Utah
Contract Type FiledAugust 17th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of August 11, 2017, is entered into by and between Growlife, Inc., a Delaware corporation (“Company”), and Chicago Venture Partners, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
Securities Purchase AgreementSecurity Agreement • February 7th, 2017 • Growlife, Inc. • Glass products, made of purchased glass • Utah
Contract Type FiledFebruary 7th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of January 9, 2017, is entered into by and between Growlife, Inc., a Delaware corporation (“Company”), and Chicago Venture Partners, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
Securities Purchase AgreementSecurity Agreement • January 22nd, 2016 • Panther Biotechnology, Inc. • Services-engineering, accounting, research, management • Utah
Contract Type FiledJanuary 22nd, 2016 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of August 20, 2015, is entered into by and between Panther Biotechnology, Inc., a Nevada corporation (“Company”), and Typenex Co-Investment, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”).